KINGKEY FIN INT (01468) is considering establishing investment opportunities and services related to cryptocurrency licenses under regulatory supervision.

05/03/2025

Kingkey Financial International (01468) has announced that the company is considering setting up investments involving cryptocurrency under the supervision of licensing.

KINGKEY FIN INT (01468) has announced that the company is currently considering establishing investment opportunities and services related to cryptocurrency licensing under regulation. The group is currently working with Amber Group to develop investment plans for the group's Bitcoin and other major cryptocurrency investment products. These investment plans will be reviewed and approved by the investment committee based on market conditions and the group's overall financial situation, and then executed by the board of directors. It is expected that the investment plans will be funded from the group's existing cash reserves.

WEIMOB INC (02013) plans to discount approximately 8.87% of the total issued shares of 6.88 billion subscription shares, raising approximately 1.55 billion HKD.

ASCLETIS-B (01672) reported the latest breakthrough research on the novel fatty acid synthase (FASN) inhibitor Dehexastat (ASC40) for the treatment of acne in a dedicated session at the 2025 European Academy of Dermatology and Venereology (EADV) annual meeting.

DL Holdings GP (01709): Purchased 2.152 million shares under the restricted stock incentive plan for the year 2025.

WEIMOB INC (02013) plans to discount approximately 8.87% of the total issued shares of 6.88 billion subscription shares, raising approximately 1.55 billion HKD.

DL Holdings GP (01709): Purchased 2.152 million shares under the restricted stock incentive plan for the year 2025.